Sunridge International Appoints Representative in the Middle East and Eastern Europe

FOUNTAIN HILLS, Ariz.,  April 21 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ), announced today the appointment of Morteza Talieh as its representative in the Middle East and Eastern Europe.  Mr. Talieh will be responsible for the expansion of Sunridge's distributor network and direct government sales to national health system within these regions.  

Mr. Talieh has over 35 years of hands-on experience in diplomacy, development, and advisory services. This experience was cultivated during residencies and assignments throughout the world, representing various international corporations, governmental agencies, and non-governmental collaborations, most notably the United Nations.

During his tenure at the U.N., he had the distinction of serving as President of United Nations' Finance Committee, in New York. Additionally, Mr. Talieh was a contributing member of ACABQ (Advisory Committee for Budget and Administration of the U. N.).  

A veteran International Civil Servant, Mr. Talieh obtained his law degree from University of Tehran, Iran. He then went on to pursue post-graduate studies at Southern Methodist University (SMU), in Dallas, Texas.  

Mr. Talieh is fluent in English, Italian, Farsi (Persian), Azari, and Turkish. He has served as liaison to foreign dignitaries, and hosted official visits and events throughout the world.  

Mr. Smith, Sunridge International's CEO, states, "The experience brought to our company by Mr. Talieh is invaluable. Between his government contacts and associations and his working experience with the World Health Organization, we feel he is the perfect candidate for this position."

Glaucoma is a serious problem in the Middle East, affecting a higher percentage of the population than normally found in Western Europe or the United States.  Sunridge International's Pneumatic Trabeculoplasty (PNT), is a 2-minute non-invasive cost effective, alternative treatment for glaucoma and ocular hypertension, and can prove to be a valuable addition to these national health systems.

SOURCE Sunridge International